Clinical trial
Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates
NCT00031460 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00031460 |
|---|---|
| Title | Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates |
| Official title | A Placebo-Controlled Phase III Evaluation of Suppressive Therapy With Oral Acyclovir Suspension Following Neonatal Herpes Simplex Virus Infections Involving the Central Nervous System |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Herpes Simplex |
| Intervention type | Drug |
| Interventions | Acyclovir, Placebo |
| Enrollment | 46 |
| Start date | Dec 1, 1997 |
| Primary completion | Feb 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Mar 7, 2002 |
| Last update posted | May 16, 2012 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: